News 
05/23/13 -
What is the “wake up juice” for biotech capitalization?
As current global growth is difficult to capture, countries are trying to focus on...
07/02/12 -
NEJM Myeloma Phase III publication
May 2012 New England Journal of Medicine published results from a phase...
03/16/12 -
Gearing up life sciences innovation to today's economic twist
This Statitec perspective paper is aiming at...
Vidéo 
Video Presentation
Key assets of Statitec :
- Taxes reduction accreditation for R&D
- Expertise in rare malignancies & ATU
- Experience in FDA submission